Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06832982RecruitingPhase 1
Study of a new drug for advanced solid tumors
This trial tests a new drug that may help people with advanced solid tumors, including liver, stomach, and brain cancers. It is for patients whose cancer has not responded to standard treatments or who cannot have them. The study aims to find the right dose and check safety and effectiveness.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07142785Recruiting
Peeling or Not Peeling for Idiopathic Epiretinal Membrane Surgery
This study compares two surgical approaches for treating an idiopathic epiretinal membrane (a thin layer of scar tissue on the retina). It aims to see whether peeling the inner layer of the retina during surgery leads to better vision and fewer visual distortions.
Hangzhou, ZhejiangAges 18 years+ - NCT05585684Recruiting
Blood test to guide next cancer treatment choices
This study checks whether a blood test can find tumor genetic changes (called “plasma genomic profiling”) to help choose the best next treatment. It may help your care team decide therapy after your cancer progresses or seems likely to progress soon.
Baltimore, MarylandAges 18 years+ - NCT07136220Recruiting
Equol for menopause symptoms in Singaporean women
This study tests if a supplement called equol can help with menopause symptoms like hot flashes and mood changes. It is for women in Singapore aged 40 to 60 who are not taking certain medications or supplements.
SingaporeAges 40–60 - NCT07135102RecruitingPhase 1
Radioactive drug for advanced prostate cancer
This study tests an experimental radioactive drug ([225Ac]Ac-PSMA-XT) that targets prostate cancer cells. It is for men whose prostate cancer has spread and stopped responding to standard hormone therapy and chemotherapy.
Jinan, ShandongAges 18 years+ - NCT07130604RecruitingPhase 3
Testing a new pill for moderate to severe plaque psoriasis
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
Beijing, Beijing MunicipalityAges 18–70 - NCT07129382RecruitingPhase 1/Phase 2
Study of CS32582 for moderate to severe plaque psoriasis
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
Beijing, Beijing MunicipalityAges 18–70 - NCT07115485RecruitingPhase 2
Study of HLX43 for advanced stomach or junction cancer
This trial tests a new drug called HLX43 (an antibody-drug conjugate targeting PD-L1) for people with advanced stomach or gastroesophageal junction cancer that has progressed after at least one prior treatment. It aims to see if it can shrink tumors and help patients live longer.
BeijingAges 3 weeks–2 months - NCT07240857Enrolling by invitationEarly Phase 1
CAR-T cell injection for advanced prostate cancer
This trial tests a new treatment called ACT#001 CAR-T cells, given as a local injection, for prostate cancer that has stopped responding to hormone therapy. It aims to see if this therapy is safe and can help shrink tumors.
Hangzhou, ZhejiangAges 18 years+ - NCT07023757Enrolling by invitation
Age and healing after tooth extraction with PRF
This study looks at how age affects healing after a tooth is removed and replaced with a bone graft using Platelet-Rich Fibrin (PRF), a natural substance from your own blood that helps healing. It may help you if you need a molar removed and plan to get an implant later.
Ann Arbor, MichiganAges 20–80 - NCT07525089Enrolling by invitation
Treatment to Clear Resistant Bacteria from Your Gut
This study tests whether a new treatment called BM111 can safely clear two types of antibiotic-resistant bacteria (CRE and VRE) that live in your intestines without causing infection. You'd provide stool samples over several weeks to see if the bacteria levels drop.
SeoulAges 19–65 - NCT06186804Enrolling by invitationPhase 2
Study of ABSK021 for chronic graft-versus-host disease
This trial tests an experimental drug (ABSK021) for people with chronic graft-versus-host disease (cGvHD) after a stem cell transplant. It may help if other treatments haven't worked well enough.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07111403Recruiting
Testing remineralizing agents for early white spots on teeth
This study tests whether a special remineralizing agent can help reverse early white spots (soft spots) on adult teeth before they become cavities. It's for people who have a few small spots but keep their teeth clean.
Al MansurahAges 14–26 - NCT07108712Recruiting
Using brain MRI to detect early white matter disease
This trial studies whether a special type of MRI can find brain white matter changes early. It might help people who have early symptoms or are at risk for diseases affecting the brain's wiring.
CairoAges 18–80 - NCT06828887RecruitingPhase 2
Testing LV232 capsules for major depression
This trial tests a new medicine called LV232 for people with moderate to severe depression. Researchers want to find the best dose and check if it works safely.
ShanghaiAges 18–65 - NCT07106957Recruiting
B5 balm for rosacea with sensitive skin
This trial tests a B5 balm (CICAPLAST BAUME B5+) to see how well it helps people with rosacea and sensitive skin. It aims to reduce redness and improve skin comfort.
BeijingAges 18–55 - NCT07105436Recruiting
Testing Thopaz Device for Persistent Lung Air Leaks
This trial tests a device called Thopaz for people who have a stubborn air leak in the lung (an air leak that hasn't healed after 5 days of chest tube drainage). The study is for those who are already scheduled for a bronchoscopy to address the leak, and aims to see if Thopaz can help stop the leak faster.
Boston, MassachusettsAges 18 years+ - NCT07104474Enrolling by invitation
RESTORE trial for nurses and hospital leaders
This trial is testing a program called RESTORE to help nursing staff and hospital leaders improve patient care. It aims to see how well the program works and how it can be used in different hospitals.
Madison, WisconsinAges 18 years+ - NCT06686134Recruiting
GLP-1 drug trial for type 2 diabetes
This trial tests a new GLP-1 receptor agonist to improve blood sugar control in people with type 2 diabetes. It may be an option if you haven't used a similar drug in the last three months and your medical records are complete.
JinanAges 18 years+ - NCT07100704RecruitingPhase 2
Nivolumab for recurrent olfactory neuroblastoma
This trial tests the drug nivolumab for people with a rare nasal tumor (olfactory neuroblastoma) that has come back or spread and cannot be treated with surgery or radiation. You must have already tried chemotherapy and it stopped working. The goal is to see if nivolumab can shrink the tumor or slow its growth.
Kashiwa, ChibaAges 18 years+ - NCT05765981RecruitingEarly Phase 1
Testing a gene therapy for AADC deficiency in young children
This early-stage trial tests VGN-R09b, a gene therapy, given to children with AADC deficiency who are not doing well on standard medicines. It aims to improve symptoms and quality of life by addressing the underlying cause of AADC deficiency.
Shanghai, No. 1678, Dongfang Road, Pudong New Area, ShanghaiAges 2–7 - NCT07088926RecruitingPhase 2
Study of a new medicine for bronchiectasis with chronic Pseudomonas infection
This study tests a new medicine (AZD0292) given through a vein for people with bronchiectasis and a chronic Pseudomonas lung infection. It aims to see if it can reduce flare-ups and improve lung health.
Orange, CaliforniaAges 12 years+ - NCT06386718Recruiting
Ultrasound of hand arteries in children
This study uses ultrasound to look at the blood vessels in the hands of children before they have surgery. It helps doctors understand hand blood flow better, which can make procedures safer.
AnkaraAges Up to 10 years - NCT06569264Recruiting
Comparing socket preservation methods after tooth extraction
This trial tests two different treatments to preserve the bone and gum after a tooth is removed. It compares using a dentin graft with I-PRF (a special blood concentrate) to the same treatment with added vitamin C. The goal is to see which helps the healing better before a dental implant.
CairoAges 18–65
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.